Q3 Earnings Estimate for Varex Imaging Issued By B. Riley

Varex Imaging Co. (NASDAQ:VREX - Free Report) - Investment analysts at B. Riley issued their Q3 2025 earnings per share (EPS) estimates for shares of Varex Imaging in a note issued to investors on Monday, May 12th. B. Riley analyst A. Schock expects that the company will post earnings of $0.03 per share for the quarter. B. Riley has a "Strong-Buy" rating on the stock. The consensus estimate for Varex Imaging's current full-year earnings is $0.53 per share. B. Riley also issued estimates for Varex Imaging's Q4 2025 earnings at $0.06 EPS, FY2025 earnings at $0.41 EPS, Q2 2026 earnings at $0.10 EPS, Q4 2026 earnings at $0.24 EPS and FY2026 earnings at $0.52 EPS.

A number of other research analysts have also weighed in on VREX. StockNews.com raised Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday, February 7th. Oppenheimer decreased their price target on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a research note on Friday, February 7th.

Varex Imaging Price Performance

NASDAQ:VREX traded down $0.07 during trading hours on Wednesday, reaching $7.81. 79,824 shares of the company traded hands, compared to its average volume of 576,172. The firm's 50-day moving average is $9.36 and its 200-day moving average is $12.52. The stock has a market cap of $321.77 million, a P/E ratio of -6.67 and a beta of 0.62. The company has a debt-to-equity ratio of 1.02, a current ratio of 4.36 and a quick ratio of 2.50. Varex Imaging has a 1-year low of $6.76 and a 1-year high of $16.93.

Varex Imaging (NASDAQ:VREX - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.14 by $0.12. The firm had revenue of $212.90 million during the quarter, compared to the consensus estimate of $206.76 million. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. The firm's revenue was up 3.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.16 EPS.

Insider Transactions at Varex Imaging

In related news, CEO Sunny Sanyal sold 8,749 shares of the stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total value of $98,338.76. Following the completion of the transaction, the chief executive officer now owns 190,193 shares of the company's stock, valued at $2,137,769.32. This represents a 4.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Kimberley E. Honeysett sold 4,007 shares of Varex Imaging stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total transaction of $51,329.67. Following the completion of the transaction, the senior vice president now owns 4,002 shares of the company's stock, valued at $51,265.62. This trade represents a 50.03% decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.

Institutional Trading of Varex Imaging

Several institutional investors and hedge funds have recently made changes to their positions in VREX. Aquatic Capital Management LLC bought a new stake in shares of Varex Imaging during the 4th quarter valued at $25,000. Quadrant Capital Group LLC boosted its stake in Varex Imaging by 115.4% in the 4th quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company's stock worth $41,000 after purchasing an additional 1,520 shares during the period. Point72 Hong Kong Ltd acquired a new position in Varex Imaging in the 4th quarter worth $48,000. Quarry LP acquired a new position in Varex Imaging in the 1st quarter worth $63,000. Finally, KLP Kapitalforvaltning AS acquired a new position in Varex Imaging in the 4th quarter worth $98,000.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.